Home > Boards > US OTC > Cannabis >

Cannabics Pharmaceuticals Inc. (CNBX)

Add CNBX Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/19/2019 11:40:12 PM - Followers: 160 - Board type: Free - Posts Today: 0





***4/12/2017 NEWS UPDATE*** 

FORBES.COM:  CNBX Added To The U.S. Marijuana Index
LINK:  https://www.forbes.com/sites/debraborchardt/2017/04/12/here-are-the-5-stocks-added-to-the-u-s-marijuana-index/#42c4f3d452e7

***4/7/2017 NEWS UPDATE*** 

Reports Success From Recent Cannabis Study On Cancer

LINK:  http://goo.gl/EIHBuC

***4/3/2017 NEWS UPDATE*** 

Cannabics Pharmaceuticals Inc. Receives the Final Report of Its
Research on Antitumor Properties of Cannabinoids Held in Israel

Itamar Borochov, CEO of Cannabics Pharmaceuticals said, "The results from this research strengthen our vision of creating anticancer treatments based on natural cannabis medicine".

LINK:  http://goo.gl/WXOXhW

Bringing Cannabinoid Diagnostics to Personalized Cancer Care

Cannabics Pharmaceuticals Inc. (CNBX), a U.S-based public company, is dedicated to the development of personalized diagnostic tools, aimed to provide supportive data for practitioners and patients regarding cannabinoid based therapy. The Company’s R&D is based in Israel, where it is licensed by the Ministry of Health for its work in both scientific and clinical research. The Company’s focus is on harnessing the therapeutic properties of natural Cannabinoid formulations. Cannabics engages in delivering the maximum amount of supportive data for cancer patients and their doctors, utilizing advanced screening systems and personalized bioinformatics tools.

View entire 24 page presentation : http://cannabics.com/presentation/

Cannabics SR' CAPSULES

Long acting oil capsule that provides a safe, effective and reliable administration of cannabis.

Cannabics SR' Capsules, Technology Description - Route of administration
There is a growing number of patients, worldwide, who could benefit from the therapeutic properties of cannabinoids. The unmet need of these patients is a safe, standardized and easy to administer cannabinoid-based therapy. Cannabinoid administration is mainly through smoking, vaporizing, sublingual and oral. While clinical studies show contradictory data regarding a correlation between smoking cannabis and respiratory diseases, most physicians agree that smoking medical cannabis, while having its benefits, is not a healthy nor standardized therapy. 

The pharmacokinetics of THC varies as a function of its route of administration. Pulmonary assimilation of inhaled THC causes a maximum plasma concentration within minutes; psychotropic effects start within seconds to a few minutes, reach a maximum after 15–30 minutes, and taper off within 2–3 hours. Following oral ingestion, psychotropic effects set in with a delay of 30–90 minutes, reach their maximum after 2–3 hours and last for about 4–12 hours, depending on dose and specific effect. Another common route of administration is sublingually. Pure cannabinoids are extracted from the raw plant, dissolved in different oils and administered with a dropper. The beneficial effect of sublingual oil administration is 2-4 hours with a fast onset due to quick absorption through the oral cavity.

The most common oral administration of cannabinoids is through eating edibles, mainly, cookies, chocolate bars and lozenges. Since absorption is attenuated when cannabinoids are ingested orally, Edibles usually contain high dosages of cannabinoids (50-300mg). The high dosage may cause undesirable side effects, mainly, dizziness, anxiety and dissociation. These side effects cause many patients to withdraw from the therapeutic process.  The oral administration route has the longest beneficial effect (4-8 hours) and lacks the undesirable effects of smoking.

Technology currently envisions the licensing of three different formulations: capsules with a 10:1 CBD to THC ratio, a 10:1 THC to CBD ratio and a balanced formulation with 1:1 THC:CBD.

Cannabics Pharmaceuticals Inc. does not manufacture, distribute, dispense or possess any controlled substances, including cannabis or cannabis based preparations. 

Cannabics Pharmaceuticals Announces a New Dosage of 5mg THC Cannabis Capsule Treating Cancer Patients Suffering from Cachexia and Anorexia Syndrome...!

BETHESDA, Maryland, Jan. 3, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) today announced development of Cannabics 5mg THC Capsule intended for naïve patient who have not tried cannabis in the past.

Dr. Eyal Ballan, Chief scientist of Cannabics Pharmaceuticals stated, "Our mission is to find the right balance between efficacy on the one hand and the elimination of undesired psychoactive effects on other."

The Cannabics 5mg THC capsule is currently being evaluated by the company in a clinical study as a palliative treatment, which is conducted by the oncology department at the prestigious Rambam Medical Center in northern Israel and under strict regulations of the Ministry of Health, by whom Cannabics Pharmaceuticals has been licensed since 2014.

The study is taking place in Israel, it is fully registered with the US NIH under "Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients", Identifier NCT02359123, and may be found at :


"The majority of our cancer trial patients have no previous experience with Cannabis, hence this recalibration of the THC level may be more amenable. We believe there is a significant potential medical market for our 5mg THC capsule in countries that have now instituted medical cannabis regulations," said Itamar Borochov, CEO of Cannabics Pharmaceuticals Inc.



What is A Cannabinoid?

You’ve heard by now that marijuana is a powerful medicinal herb. But, just how powerful is it? The list of medical benefits for these top 10 cannabinoids seems endless.



Security Details Share Structure
  Market Value1 $72,404,107 a/o Jan 13, 2017
Authorized Shares 900,000,000 a/o Dec 30, 2016
Outstanding Shares 107,265,344 a/o Dec 30, 2016
-Restricted 90,368,887 a/o Dec 30, 2016
-Unrestricted 16,896,457 a/o Dec 30, 2016
  Held at DTC Not Available
Float 14,295,638 a/o Jun 30, 2016
  Par Value 0.0001

CNBX Security Details Share Structure
  Market Value1 $37,994,466 a/o Oct 28, 2016
  Authorized Shares 900,000,000 a/o Jul 09, 2015
  Outstanding Shares 107,026,665 a/o Jun 30, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 18,737,071 a/o Jun 30, 2016
  Par Value 0.0001

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CNBX News: Quarterly Report (10-q) 04/15/2019 12:38:47 PM
CNBX News: Current Report Filing (8-k) 02/13/2019 09:27:46 AM
CNBX News: Quarterly Report (10-q) 01/17/2019 10:39:42 AM
CNBX News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 01/14/2019 05:01:42 PM
CNBX News: Annual Report (10-k) 11/29/2018 02:39:03 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#4052   I'm with Etrade. jim992 05/19/19 11:40:12 PM
#4051   Check out L2 on tdameritrade H_dog_taco 05/19/19 11:49:48 AM
#4050   I see comments about MAXM buying up shares. jim992 05/19/19 04:23:27 AM
#4049   Not much liquidity here, nobody is letting go H_dog_taco 05/16/19 02:57:18 PM
#4048   MAXM has been on the BID for days... GP65 05/16/19 12:29:33 PM
#4047   Thanks Jim!!! Still fairly new to DD H_dog_taco 05/15/19 08:39:40 AM
#4046   I like your last 3 posts and like jim992 05/15/19 01:18:19 AM
#4045   I read that TSX has a sandbox program H_dog_taco 05/13/19 11:22:24 PM
#4044   This company (and this baord) is in stealth H_dog_taco 05/13/19 04:27:14 PM
#4043   The last 3 months of trading action here H_dog_taco 05/13/19 01:09:20 PM
#4042   How long does something like this typically take jim992 05/13/19 02:54:58 AM
#4041   L2 lets you see market makers, the entities H_dog_taco 05/10/19 08:33:36 AM
#4040   To clarify, on the ask for CNBX? jim992 05/10/19 01:24:43 AM
#4039   I think something may be up. MAXM market H_dog_taco 05/09/19 03:09:47 PM
#4038   Exciting swings! goodfree 05/09/19 02:05:40 PM
#4037   If you get a chance to review it jim992 05/04/19 02:14:59 AM
#4036   There’s the TSX and the TSX-V, plus the WallyWest 05/04/19 01:54:08 AM
#4035   BigFred, I apologize, I responded too quickly. WallyWest 05/04/19 01:47:50 AM
#4034   That’s revenue, not profitability. They’re still incurring a WallyWest 05/04/19 01:35:12 AM
#4033   If you look at the quarterly report from bigfred1 05/03/19 05:20:25 PM
#4032   I think this is the podcast I heard H_dog_taco 05/03/19 04:17:33 PM
#4031   Fantastic info and insight WallyWest!! jim992 05/03/19 02:45:38 PM
#4030   Hi WallyWest, jim992 05/03/19 02:39:51 PM
#4029   Hi WallyWest, jim992 05/03/19 02:31:43 PM
#4028   Probably go for CSX surfgreen 05/03/19 12:15:41 PM
#4027   I hope they don’t go down that road. WallyWest 05/03/19 02:53:41 AM
#4026   They’re all different, but if you track their WallyWest 05/03/19 02:46:43 AM
#4025   I think you’re looking at the wrong exchange. WallyWest 05/03/19 02:25:09 AM
#4024   CNBX isn’t profitable. It’s still operating at WallyWest 05/03/19 02:21:40 AM
#4023   I believe those reports only carry stocks at WallyWest 05/03/19 02:19:39 AM
#4022   I would be surprised if they went to WallyWest 05/03/19 02:18:43 AM
#4021   Jim is saying TSX is for 5 dollars bigfred1 05/03/19 12:44:52 AM
#4020   Thanks WallyWest. Are the other companies jim992 05/02/19 11:32:42 PM
#4019   From what Wiki provides, unlike its listing in jim992 05/02/19 11:28:17 PM
#4018   I just checked that GWPH is reporting in bigfred1 05/02/19 10:09:40 PM
#4017   CEO said they were going to list on TSX. H_dog_taco 05/02/19 08:41:51 AM
#4016   I don’t think they’re ready for a big WallyWest 05/02/19 02:31:48 AM
#4015   Hi bigfred1, jim992 05/02/19 12:10:14 AM
#4014   I would also like to know if they jim992 05/02/19 12:04:17 AM
#4013   Thx Jim. You remember that I tried to bigfred1 05/01/19 10:56:45 PM
#4012   That's awesome!!!! I think this is going to H_dog_taco 05/01/19 02:25:37 PM
#4011   Shares remain the same. Stock price usually gets surfgreen 05/01/19 11:25:30 AM
#4010   Did you listen to the podcast this last H_dog_taco 05/01/19 09:53:08 AM
#4009   Hi bigfred1, jim992 05/01/19 01:22:30 AM
#4008   Hello Jim: bigfred1 04/29/19 11:32:09 PM
#4007   https://www.prnewswire.com/il/news-releases/cannabics-pharmaceuticals-ceo-to-pre Pierpont 04/25/19 11:16:45 PM
#4006   Everybody is waiting for this to break the H_dog_taco 04/24/19 01:58:49 PM
#4005   What an anemic volume. What gives? truffleberry 04/24/19 01:34:08 PM
#4004   They mentioned getting listed on the canadian exchange H_dog_taco 04/23/19 02:12:13 PM
#4003   It's their super tight share structure/short squeeze that H_dog_taco 04/23/19 08:53:12 AM